Gables Capital Management Inc. Merck & Co., Inc. Transaction History

Gables Capital Management Inc.

$189 Million
Q2 2024

A detailed history of Gables Capital Management Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gables Capital Management Inc. holds 15,837 shares of MRK stock, worth $1.87 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

15,837

Previous 15,987 0.94%

Holding current value

$1.87 Million

Previous $2.11 Million 7.06%

% of portfolio

1.04%

Previous 1.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$123.8 - $132.96 $18,570 - $19,944	-150 Reduced 0.94%	15,837 $1.96 Million
Q1 2024 May 03, 2024	SELL	$113.24 - $131.95 $11,324 - $13,194	-100 Reduced 0.62%	15,987 $2.11 Million
Q4 2023 Feb 07, 2024	SELL	$100.18 - $109.02 $9,517 - $10,356	-95 Reduced 0.59%	16,087 $1.75 Million
Q3 2023 Nov 02, 2023	SELL	$102.95 - $114.33 $1,647 - $1,829	-16 Reduced 0.1%	16,182 $1.67 Million
Q2 2023 Aug 02, 2023	BUY	$108.61 - $118.38 $14,662 - $15,981	135 Added 0.84%	16,198 $1.87 Million
Q1 2023 May 03, 2023	BUY	$102.94 - $114.86 $4,426 - $4,938	43 Added 0.27%	16,063 $1.71 Million
Q4 2022 Feb 03, 2023	SELL	$87.44 - $112.11 $3,060 - $3,923	-35 Reduced 0.22%	16,020 $1.78 Million
Q2 2022 Jul 18, 2022	BUY	$83.49 - $94.64 $12,523 - $14,196	150 Added 0.94%	16,055 $1.46 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $5,734 - $6,306	-80 Reduced 0.5%	15,905 $1.2 Million
Q2 2021 Aug 03, 2021	SELL	$70.31 - $77.77 $763,285 - $844,271	-10,856 Reduced 40.45%	15,985 $1.24 Million
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $82,632 - $97,332	-1,200 Reduced 4.28%	26,841 $2.07 Million
Q4 2020 Feb 03, 2021	SELL	$71.77 - $79.65 $35,885 - $39,825	-500 Reduced 1.75%	28,041 $2.29 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $8,708 - $9,871	-119 Reduced 0.42%	28,541 $2.37 Million
Q2 2020 Jul 30, 2020	BUY	$70.42 - $80.13 $42,956 - $48,879	610 Added 2.17%	28,660 $2.22 Million
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $51,638 - $71,573	815 Added 2.99%	28,050 $2.16 Million
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $105,896 - $119,492	-1,365 Reduced 4.77%	27,235 $2.48 Million
Q3 2019 Oct 30, 2019	BUY	$76.08 - $82.93 $216,828 - $236,350	2,850 Added 11.07%	28,600 $2.41 Million
Q2 2019 Jul 31, 2019	BUY	$69.84 - $81.59 $85,903 - $100,355	1,230 Added 5.02%	25,750 $2.16 Million
Q1 2019 Apr 30, 2019	BUY	$69.58 - $79.36 $26,788 - $30,553	385 Added 1.6%	24,520 $2.04 Million
Q4 2018 Feb 08, 2019	SELL	$65.24 - $75.71 $48,929 - $56,782	-750 Reduced 3.01%	24,135 $1.84 Million
Q3 2018 Nov 05, 2018	BUY	$57.69 - $67.84 $3,749 - $4,409	65 Added 0.26%	24,885 $0
Q2 2018 Aug 03, 2018	BUY	$50.83 - $59.72 $33,293 - $39,116	655 Added 2.71%	24,820 $1.49 Million
Q1 2018 May 17, 2018	BUY	$50.96 - $59.23 $1.23 Million - $1.43 Million	24,165 New	24,165 $1.32 Million

Others Institutions Holding MRK

# of Institutions

3,825

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $299B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.

Account

Gables Capital Management Inc. Merck & Co., Inc. Transaction History